Media Coverage

In a world-first for sports science, OxiDx, a majority-owned subsidiary of ASX-listed biotechnology ...

Australian researchers have made a breakthrough in endometriosis detection amid the development of a...

Australian researchers have developed an “exciting” new blood test which could help diagnose women w...

Endometriosis blood test could reduce diagnosis times and improve care

Proteomics International’s share price surged as much as 24 per cent today on the best volume in mor...

An Australian blood test for endometriosis raises the prospect of a quicker diagnosis of one of the ...

An Australian breakthrough is set to revolutionise treatment for women with endometriosis. A simple ...

Proteomics International has reported positive results from the clinical validation study of its Pro...

People living with type 1 diabetes may be able to manage, treat and potentially avoid kidney decline...

Proteomics International Laboratories testing using its “PromarkerD” device that employs a simple bl...

Kidney disease is a serious issue in Australia and globally and yet despite the social and economic ...

Proteomics International’s Managing Director Dr Richard Lipscombe was interviewed by Shares in Value...

Proteomics International said Monday that it has signed a deal with Eurobio Scientific for the exclu...

Proteomics International Laboratories has sealed a new deal with medical diagnostics company Eurobio...

Proteomics International Laboratories is escalating its expansion into the European market after app...

Having served as Proteomics chief since he-co founded the company in 2001, Dr Richard Lipscombe is u...

A recent study at the university’s Centre for Crop and Disease Management (CCDM) in Western Australi...

Having previously confirmed dieback is resistant to chemical control on crops such as avocados, ston...

ASX-listed Proteomics has joined forces with England’s revered Oxford University as the medtech cont...

Proteomics International said it has signed a material transfer agreement with the University of Oxf...

Proteomics International Head of Clinical Studies Dr Kirsten Peters was featured on the opening epis...

Proteomics International Laboratories will continue important research and development for its diagn...

Proteomics International Laboratories’ 66 per cent-owned subsidiary OxiDx has been awarded a Europea...

Dr Richard Lipscombe, Managing Director of Proteomics International (ASX:PIQ), spoke with 2GB’s Heal...